SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-22-000016
Filing Date
2022-05-09
Accepted
2022-05-09 16:07:03
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20220331.htm   iXBRL 10-Q 959046
2 EX-31.1 krys-20220331ex311.htm EX-31.1 10783
3 EX-32.1 krys-20220331ex321.htm EX-32.1 11254
4 EX-32.2 krys-20220331ex312.htm EX-32.2 10746
10 GRAPHIC krys-20220331_g1.jpg GRAPHIC 455128
  Complete submission text file 0001711279-22-000016.txt   6267833

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20220331.xsd EX-101.SCH 37074
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20220331_cal.xml EX-101.CAL 57110
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20220331_def.xml EX-101.DEF 153739
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20220331_lab.xml EX-101.LAB 484608
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20220331_pre.xml EX-101.PRE 310042
52 EXTRACTED XBRL INSTANCE DOCUMENT krys-20220331_htm.xml XML 856381
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 22904907
SIC: 2836 Biological Products, (No Diagnostic Substances)